1. Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev. 2000; 21:168–99.
Article
2. Bahn RS. Graves' ophthalmopathy. N Engl J Med. 2010; 362:726–38.
Article
3. Borumandi F, Hammer B, Kamer L, von Arx G. How predictable is exophthalmos reduction in Graves' orbitopathy? A review of the literature. Br J Ophthalmol. 2011; 95:1625–30.
Article
4. Borumandi F, Hammer B, Noser H, Kamer L. Classification of orbital morphology for decompression surgery in Graves' orbitopathy: two-dimensional versus three-dimensional orbital parameters. Br J Ophthalmol. 2013; 97:659–62.
Article
5. McKeag D, Lane C, Lazarus JH, et al. Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey. Br J Ophthalmol. 2007; 91:455–8.
Article
6. Mourits MP, Bijl H, Altea MA, et al. Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures. Br J Ophthalmol. 2009; 93:1518–23.
7. Baujat B, Krastinova D, Bach CA, et al. Orbital morphology in exophthalmos and exorbitism. Plast Reconstr Surg. 2006; 117:542–50.
Article
8. Campi I, Vannucchi GM, Minetti AM, et al. A quantitative method for assessing the degree of axial proptosis in relation to orbital tissue involvement in Graves' orbitopathy. Ophthalmology. 2013; 120:1092–8.
Article
9. Dickinson AJ, Perros P. Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. Clin Endocrinol (Oxf). 2001; 55:283–303.
Article
10. Vardizer Y, Berendschot TT, Mourits MP. Effect of exophthalmometer design on its accuracy. Ophthal Plast Reconstr Surg. 2005; 21:427–30.
Article